Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Semaglutide trade name?Amoxicillin clavulanate potassium uses?E56 pill imprint quetiapine 300 mg manufacturer?Oral doxycycline hyclate market size?Evaluate the diabetes company trulicity on biosimilar generic competition?
See the DrugPatentWatch profile for Repatha
No. As of the information provided here, a true generic version of Repatha (evolocumab) is not available. Repatha is a biologic, and biologic competitors typically come to market as biosimilars rather than “traditional” generics.
Yes. For biologics like Repatha, the relevant question is whether any biosimilar has been approved (by regulators such as the FDA) and is being sold in place of the reference product. If a biosimilar is not approved/marketed, then a “generic Repatha” effectively is not available either.
DrugPatentWatch.com tracks biologic/drug patent and exclusivity status and can help you see whether biosimilar competition is expected or already emerging. You can check Repatha-related coverage here: https://www.drugpatentwatch.com/
Other Questions About Repatha :